Jay R. Luly, President and CEO at ENANTA PHARMACEUTICALS INC (ENTA), sold 5,800 shares at $37.81 ($221K) on 2014-02-14, disclosed to the SEC on 2014-02-14.
Scheduled sale ($221k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.81 | 3,415 | $129K | 58.4% |
| 2 | $38.52 | 2,385 | $92K | 41.6% |
| Total | $38.10 avg | 5,800 | $221K | 100% |
| Filing → |
| ENTA | SELL | 2024-12-10 | $41K | — | Filing → |
| ENTA | SELL | 2023-12-06 | $139K | — | Filing → |
| ENTA | SELL | 2023-03-14 | $2.5M | — | Filing → |